JWH-220

JWH-220 is a synthetic cannabinoid that acts as a potent agonist at the cannabinoid receptors. It is part of the naphthoylindole family of compounds, which were originally developed for research purposes to study the endocannabinoid system.

Chemical Structure and Properties

JWH-220 is chemically classified as a naphthoylindole, with the IUPAC name 1-Pentyl-3-(4-ethyl-1-naphthoyl)indole. The compound has a molecular formula of C₂₆H₂₇NO and a molecular weight of 369.50 g/mol. The structure consists of a naphthalene ring system attached to an indole core, with a pentyl chain at the nitrogen atom of the indole and an ethyl group at the 4-position of the naphthoyl moiety.

Pharmacology

JWH-220 is a full agonist at the CB₁ and CB₂ cannabinoid receptors, with a higher affinity for the CB₁ receptor. This receptor is primarily found in the central nervous system and is responsible for the psychoactive effects of cannabinoids. The activation of these receptors by JWH-220 leads to a range of effects, including analgesia, sedation, and alterations in mood and perception.

Research and Applications

JWH-220, like other synthetic cannabinoids, has been used in scientific research to better understand the endocannabinoid system and its role in various physiological processes. Studies involving JWH-220 have contributed to the knowledge of cannabinoid receptor interactions and the potential therapeutic applications of cannabinoids in pain management, neuroprotection, and other medical conditions.

Legal Status

The legal status of JWH-220 varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. Researchers working with JWH-220 must comply with regulatory requirements and obtain appropriate licenses to handle the compound.

Safety and Toxicology

The safety profile of JWH-220 has not been extensively studied in humans. However, as with other synthetic cannabinoids, there is a potential for adverse effects, including anxiety, paranoia, tachycardia, and other cardiovascular issues. The long-term effects of JWH-220 use are not well understood, and caution is advised when handling or studying this compound.

Also see

• Synthetic cannabinoids
• Cannabinoid receptor
• Endocannabinoid system
• JWH-018
• CB1 receptor
• CB2 receptor